会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Branch prediction device and method that breaks accessing a pattern history table into multiple pipeline stages
    • 分支预测装置和方法,其将模式历史表访问中断到多个流水线阶段
    • US08892852B2
    • 2014-11-18
    • US12178218
    • 2008-07-23
    • Yasuo Ishii
    • Yasuo Ishii
    • G06F9/38
    • G06F9/3848G06F9/3844
    • A branch prediction device capable of preventing degradation of branch prediction accuracy and a delay in processing speed is provided. The branch prediction device includes a branch prediction information accumulation processing section which stores branch prediction groups in which a plurality of pieces of branch prediction information are grouped, and performs accumulation-processing of the branch prediction information. The branch prediction device further includes a pipeline access control section which performs processing, upon request, by pipeline processing, including first selection control processing for selection-controlling at least one branch prediction group from the branch prediction groups, and second selection control processing for selection-controlling one or a plurality of pieces of branch prediction information from the branch prediction group, and controls an access to the branch prediction information accumulation processing section.
    • 提供了能够防止分支预测精度下降和处理速度延迟的分支预测装置。 分支预测装置包括分支预测信息累积处理部分,其存储多条分支预测信息被分组的分支预测组,并且执行分支预测信息的累积处理。 分支预测装置还包括:流水线访问控制部分,根据请求,通过流水线处理执行处理,包括用于从分支预测组中选择控制至少一个分支预测组的第一选择控制处理和用于选择的第二选择控制处理 - 从分支预测组控制一条或多条分支预测信息,并控制对分支预测信息累积处理部分的访问。
    • 8. 发明授权
    • Surfactant for emulsion polymerization
    • 乳液聚合用表面活性剂
    • US07098250B2
    • 2006-08-29
    • US10344851
    • 2001-09-10
    • Hiroki SawadaYasuo IshiiTakayuki Ikenaga
    • Hiroki SawadaYasuo IshiiTakayuki Ikenaga
    • B01F17/00B01F3/08
    • C08F16/26C08F2/26C08F16/30
    • The invention provides a surfactant for emulsion polymerization represented by the formula (I), (II) or (VI). The invention also provides a method of producing a polymer emulsion using this surfactant. wherein A represents an alkylene group having 3 to 18 carbon atoms or an alkoxymethylethylene group (alkoxy group has 4 to 18 carbon atoms), EO represents an oxyethylene group, a denotes a number of 0 to 50, b denotes a number of 0 to 200 wherein a and b are not 0 at the same time and M represents a cation; wherein A′O represents an oxyalkylene group having 3 to 18 carbon atoms, E′O represents an oxyethylene group, m denotes a number of 0 to 50 and n denotes a number of 5 to 200, provided that the -(A′O)— groups m in number [-(A′O)m-] may be the same as or different from one another.
    • 本发明提供了由式(I),(II)或(VI)表示的用于乳液聚合的表面活性剂。 本发明还提供了使用该表面活性剂制备聚合物乳液的方法。 其中A表示碳原子数为3〜18的亚烷基或烷氧基甲乙基(烷氧基为碳原子数4〜18),EO为氧亚乙基,a为0〜50的数,b为0〜200的数 其中a和b不同时为0,M为阳离子; 其中A'O表示碳原子数3〜18的氧化烯基,E'O表示氧化乙烯基,m表示0〜50的数,n表示5〜200的数,条件是 - (A'O) - 数字[ - (A'O)m-]中的基团可以彼此相同或不同。
    • 9. 发明授权
    • Ophthalmological composition comprising activated vitamin D
    • 包含活化的维生素D的眼科组合物
    • US06248732B1
    • 2001-06-19
    • US08913522
    • 1997-11-24
    • Seiji ItohYasuo IshiiKatsuhiko Mukai
    • Seiji ItohYasuo IshiiKatsuhiko Mukai
    • A61K3159
    • A61K31/593A61K31/59A61K31/592Y10S514/912A61K2300/00
    • An ophthalmic composition comprises active vitamin D as an effective component and is used for preventing deterioration of the optical transparency, occurrence of high intraocular pressure diseases or defective sight, observed after an ophthalmic operation, due to hyperplasia of the anterior ocular cells in the tissues damaged by the ophthalmic operation, which are in course of a healing process, and/or excess production of cellular materials. The ophthalmic composition can be dropped in the eye after operations such as those for cataract, for transplantation of intraocular lenses and for cornea to maintain the intraocular transparency of the anterior ocular region, to control the hyperplasia of the anterior ocular cells in the tissues damaged by the ophthalmic operation, which are in course of a healing process, and/or excess production of cellular materials and to thus prevent any reduction of visual acuity.
    • 一种眼用组合物包含活性维生素D作为有效成分,用于防止眼部手术后观察到的光学透明度降低,高眼内压疾病或视力缺陷,由于组织中前眼细胞的增生受损 通过眼科手术,其处于愈合过程的过程中和/或细胞材料的过量产生。眼科组合物可以在诸如白内障手术,眼内透镜移植和角膜维持等手术后滴入眼中 眼前区域的眼内透明度,以控制由眼科手术损伤的组织中的前眼细胞的增生,其在愈合过程中,和/或细胞材料的过量产生并因此防止任何还原 的视力。